Introduction Semaglutide has rapidly gained recognition as a transformative medication in the treatment of type 2 diabetes and obesity. Initially developed for diabetes management, Semaglutide belongs to a class of drugs known as GLP-1 receptor agonists. These medications mimic the actions of a naturally occurring hormone in the body, glucagon-like https://trevoruydfi.hyperionwiki.com/981140/semaglutide_transforming_the_landscape_of_diabetes_and_weight_management